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Abstract 
 
Background: Heart failure (HF) is a major healthcare problem contributing significantly to hospital admission 
stays and National Health Service (NHS) spending. Reducing length of hospital stay (LoS) in HF is 
paramount in reducing this burden and is influenced by factors relating to the condition, sociodemographics 
and comorbidities. Psychiatric comorbidities are being increasingly identified amongst HF patients but their 
impact on LoS has not been studied in the UK.  
 
Methods: We investigated the impact of psychiatric comorbidities on LoS amongst 31760 HF patients 
admitted to hospitals in North England between 1st January 2000 and 31
st
 March 2013 from the ACALM 
(Algorithm for Comorbidities, Associations, Length of stay and Mortality) study. The ACALM protocol uses 
ICD-10 and OPCS-4 coding to trace HF patients, psychiatric comorbidities and demographics including LoS.   
 
Results: Amongst 31760 HF patients mean LoS in the absence of psychiatric comorbidities was 11.2 days. 
Presence of a psychiatric comorbidity increased LoS by 3.3 days. Logistic regression accounting for age, 
gender and ethnicity showed that LoS was significantly longer in patients suffering from depression (3.4 
days,p<0.001), bipolar disorder (8.8 days,p<0.001) and all types of dementia (4.2 days,p<0.001).  
 
Conclusions: Our results demonstrate that psychiatric comorbidities have a significant and clinically 
important impact on LoS in HF patients in the UK. Clinicians should be actively aware of psychiatric 
conditions amongst HF patients and manage them to reduce LoS and ultimately the risk for patients and 
financial burden for the NHS. 
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Introduction 
Heart failure is an important pandemic affecting 26 million people globally
1
. In the United Kingdom alone it 
affects approximately 900 000 patients
2
 and with a short survival time it is one of the leading causes of 
death
3
. 10-year mortality rate was estimated to be 42.8% by the NHANES-1 study which is comparable to 
the mortality rate associated with cancer 
4,5
. This high morbidity and mortality means that heart failure 
consequently has a considerable global economic burden, which has been estimated to be $108 billion  
(€100 billion) annually
6
. Expensive pharmacological treatments, community care and the frequent and 
pronged hospital admissions
7,8
 associated with the clinical course of the disease are important contributors 
to these costs. As a result, heart failure patients consume a considerable proportion of National Health 
Service (NHS) spending on hospital admissions, contributing 2% of all NHS in-patient bed-days and 5% of 
emergency admissions
2
. The average cost of a non-elective inpatient stay for heart failure patients is £1542 
($2300 or €2100) and every excess day costs £275 ($410 or €380) 
9
. The burden of prolonged stays in heart 
failure patients is further demonstrated by the fivefold greater costs associated with an increase in length of 
hospital stay (LoS) from <4days to >7 days
10
, so it is essential that steps are taken to prevent prolonged 
inpatient stay. Reducing LoS could also prevent serious complications associated with hospital admissions, 
such as hospital-acquired infections which have a prevalence of 6.4%
11
 and contribute significantly to 
mortality. These problems associated with extended LoS will become increasingly important as the burden of 
the disease rises with an ageing population and improved survival from the condition
12
. Optimising the timing 
of hospital discharge in heart failure patients could combat the health and social implications for the patient 
and financial implications for the NHS associated with prolonged LoS . 
 
Research examining the determinants of prolonged length of stay in heart failure patients is therefore 
required. Although these factors have not been extensively studied there is some evidence for LoS being 
influenced by a number of factors relating to the condition such as the aetiology
13
 and disease severity
14
, 
clinical presentation
15
, the ejection fraction
14
 and the presence of peripheral oedema
10
. Other medical factors 
include those relating to treatment of heart failure, such as the duration of intravenous diuretic therapy
10
, use 
of harmful drugs
16
 or development of iatrogenic complications
17
. Also important are socio-demographic 
factors
18,19
 or the presence of either social problems or medical comorbidities which require treatment 
10, 18, 19, 
20, 
of which various studies demonstrated renal impairment as a particularly important determinant of LoS in 
heart failure. These factors could be targeted; although the literature suggests LoS for heart failure patients 
has been shortening over recent times
21
 so this data from older studies may not be relevant. As the LoS is 
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heavily influenced by NICE guidelines and protocols, newer studies based in the United Kingdom may 
identify new and more relevant determinants of length of stay to focus on.  
 
An array of studies have demonstrated that suffering from comorbid psychiatric conditions are associated 
with significantly longer LoS
,23,24,25,26
 ranging from an extra 2.5 to 8.2 days in hospital
27
. Furthermore, a large 
review of 26 international outcome studies which were all focused on LoS in medical and surgical inpatients 
with comorbid psychiatric disease, LoS was increased and in particular was prolonged by diagnoses of 
dementia, delirium, depression and personality disorders
28
. These longer admission times represent a 
significant financial burden, with 1 in every £8 ($12 or €10) of NHS spending estimated to be spent on 
psychiatric comorbidities. These detectable and manageable conditions are thus an important putative 
determinant of LoS in heart failure patients. The evidence for a similar impact of psychiatric conditions on 
LoS in heart failure patients is limited. Hochlenehert et al demonstrated that cardiovascular inpatients in a 
German university hospital diagnosed with psychiatric conditions by the treating clinicians stayed in hospital 
for an average of 3 days longer
29
. This has been translated in the context of heart failure more specifically. In 
a study of 21,429 American patients LoS for those with a coded psychiatric comorbidity stayed in hospital up 
to 1.4 days longer and hospital costs for these patients were up to $7 763 higher
30
. Aside from the financial 
cost, the LoS also has important implications on other clinical outcomes and is associated with increased 
readmission and higher mortality rates at 30 days and 1 year
31
. These studies together emphasise the 
importance of reducing costs and improving patient outcomes by reducing the LoS, but more studies are 
required to characterise the impact of psychiatric conditions in heart failure patients in the United Kingdom 
specifically.  
 
With this in mind we aimed to study the impact of psychiatric comorbidities on LoS in a large database of 
patients admitted to hospitals in the North of England with heart failure. It has been previously demonstrated 
in two papers using this database that there is a large burden of cardiovascular disease amongst patients 
with psychiatric disease, with approximately 1 in 4 suffering from a cardiovascular comorbidity
32,33
. 
Psychiatric and cardiovascular disease is commonly seen together but the impact of these conditions on 
outcomes such as LoS should be studied further. 
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Methods 
Study Population 
We examined the impact of psychiatric co-morbidity on LoS in patients diagnosed with heart failure using an 
entirely anonymous database of adult patients compiled using the ACALM (Algorithm of Comorbidities, 
Associations, Length of stay and Mortality) study protocol which has been previously used and described by 
our group
32-46
. The ACALM study protocol uses ICD-10 (International Classification of Diseases and Related 
Health Problems, revision 10) diagnosis and OPCS-4 (Office of Population Censuses and Surveys 
Classification of Interventions and Procedures, version 4) procedure codes to identify patients from 
completely anonymous electronic hospital records.  
 
The study population consisted of all 929 552 adult patients admitted to seven hospitals in North of England, 
UK, between 1
st
 January 2000 and 31
st
 March 2013. This start date was selected because it is when ICD-10 
coding started being used widely in the hospitals included in the study. For patients with several 
hospitalizations, only the LoS data for their first hospitalization was included in the study. The target 
population we studied consisted of all 31 760 heart failure patients (3.4%) that were hospitalized during the 
study period. All patients with heart failure, diagnosed according to NICE guidelines
2
, and given an ICD-10 
code for heart failure were included. Patients under the age of 18 were excluded. Data on LoS, age, gender, 
ethnicity, mortality and co-morbidities were available for all patients.  
 
Psychiatric Co-morbidities 
The ACALM protocol was also used to identify patients coded for any psychiatric conditions. Anonymous raw 
information of registered discharge diagnoses of all patients admitted to seven hospitals in North of England, 
UK between 1
st
 January 2000 and 31
st
 March 2013 were received from the computerized analysis register of 
the local health authority. The ACALM protocol was then applied to transfer this raw data into an anonymous 
research database. 
 
Psychiatric co-morbidities were traced using ICD-10 and OPCS-4 coding. We included any of psychiatric co-
morbidity with a prevalence of 0.1% or greater for analysis. This consisted of the following ICD-10 codes; 
alcohol abuse, anxiety, bipolar disorder, all types of dementia, depression, opioid abuse, overdose, 
parasucide, phobic disorders and schizophrenia.  Physical comorbidities were also analysed as a 
comparison (type 2 diabetes mellitus, hypertension, chronic kidney disease, cerebrovascular disease, atrial 
fibrillation and anaemia). The final diagnoses, co-morbidities and procedural codes entered for each patient 
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is taken from the discharge diagnosis and therefore includes clinical information that becomes available later 
in the hospital stay. 
 
Data Analysis 
SPSS version 20.0 (SPSS Inc. Chicago, IL) was used for data analysis. To examine the impact of each 
psychiatric co-morbidity on length of stay a Student’s t test was applied comparing mean LoS in patients with 
and without each co-morbidity in turn. A Levene’s test for equality of variances was applied prior to the t test. 
P values were calculated two-tailed and p<0.05 were taken as significant. The methodology has been 
previously described and similarly used by our group and other groups previously.  
 
Research Governance  
The data used in this study was completed anonymous, non-identifiable and non-traceable.  Appropriate 
ethics and research and development approvals were sought and obtained.     
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Results 
Out of 929 552 patients admitted during the study period there were 31 760 patients (3.4%) with heart 
failure. Demographics of the heart failure population are shown in table 1. The mean age of heart failure 
patients was 73.6, 50.3% were male and the majority were of Caucasian origin (85.1%). The majority of 
patients (66.4%) died during the study period. 
 
The prevalence of psychiatric co-morbidities amongst heart failure patients were analysed and 12.7% were 
found to have at least one. All of the psychiatric co-morbidities with a prevalence of at least 0.1% amongst 
the heart failure patients are shown in table 2 and include; all types of dementia(6.78%), depression (3.23%), 
alcohol abuse (1.83%), anxiety disorders (1.10%), schizophrenia (0.56%), opioid abuse (0.26%), bipolar 
disorder (0.18%), parasuicide (0.15%), phobic disorders (0.14%) and overdose (0.12%). 
 
To investigate the impact of these psychiatric co-morbidities on the LoS of heart failure patients Student’s t 
tests were applied comparing the mean LoS in patients with and without each comorbidity. The mean LoS of 
heart failure patients with no psychiatric co-morbidities was 11.2 days. If any psychiatric co-morbidity was 
present this was significantly longer by 3.3 days (2.6-3.9, 95% CI). LoS in heart failure patients was 3.4 days 
longer in those suffering from co-morbid depression (2.1-4.7 days, 95% CI) and longer by 8.8 days in those 
with bipolar disorder (2.6-3.9, 95% CI). In particular, co-morbid dementia was associated with LoS ; by 4.2 
days with a diagnosis of any type of dementia (3.3-5.1, 95% CI)).  Of the patients with a psychiatric co-
morbidity, patients with a single psychiatric co-morbidity  were most common and these patients had 
significantly longer LoS compared to patients without psychiatric co-morbidities (3.6 days; 2.6-4.7 95% CI).  
Patients with two psychiatric co-morbidities also tended to have a longer LoS but this was not statistically 
significant due to a small number of patients (Table 2).   
 
The prevalence of a selection of physical comorbidities amongst heart failure patients was also analysed as 
a comparison and are shown in table 2. LoS was significantly shorter in heart failure patients with comorbid 
Type 2 Diabetes (1.1 days shorter, 0.5 – 1.6 days 95% CI) and Hypertension (1.4 days shorter, 1.0-1.9 days, 
95% CI). Patients with all other physical comorbidities had significantly longer LoS stay compared to heart 
failure patients without each comorbdiity. LoS was longer by 9.0 days (8.2-9.8 days, 95% CI) in patients with 
comorbid Cerebrovascular Disease, by 1.5 days (0.8-2.1 days, 95% CI) in comorbid Chronic Kidney 
Disease, 1.8 days (1.3-2.3 days, 95% CI) in comorbid Atrial Fibrillation and 3.7 days (3.0-4.4 days, 95% CI) 
in comorbid Anaemia. 
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Discussion 
The results of our study show that heart failure patients with any comorbid psychiatric condition have a 
significantly longer LoS compared to those without one. This was most marked in patients suffering with 
comorbid bipolar disorder, followed by any type of dementia and depression. These  findings have important 
implications for the efficient economical management of heart failure.  
 
Our results are concordant with previous studies demonstrating a significantly longer LoS in inpatients with 
psychiatric conditions, and more specifically in those with comorbid cognitive impairment
22.23,24,25,28
 
 
and 
depression
28
. This was also true of patients with bipolar disorder, who had the longest LoS in our study. 
None of these prior studies were focused on heart failure patients though and only Sayers et al have studied 
the impact of psychiatric conditions in heart failure patients specifically. Although they demonstrated a longer 
LoS in heart failure patients with psychiatric comorbidities it was only prolonged by 1.4 days, they only 
included patients over the age of 65, and, they did not analyse the specific psychiatric comorbidities 
contributing to this increased LoS. We have therefore demonstrated a more clinically significant prolongation 
of LoS by psychiatric comorbidities in heart failure patients and have provided novel evidence as to which 
conditions are contributing. Furthermore, to our knowledge, this is the first study that has demonstrated that 
psychiatric comorbidities lengthen hospital stay in heart failure patients in the UK. Given that the length of 
hospitalisations and their overall financial costs depend greatly on service provisions and protocols in 
different countries this is an important finding.  
  
There are an array of mechanisms by which these psychiatric comorbidities could be leading to an increased 
duration of hospitalisation in heart failure patients. Pharmacological mechanisms such as complications of 
treatments for psychiatric comorbidities or poor mental health interfering with adherence to heart failure 
treatment could be contributing. Underlying pathophysiological mechanisms such as activation of the 
hypothalamic-pituitary-adrenal axis, which occurs in depression, has also been proposed.
30 
Similarly more 
social and pragmatic reasons could be important such as poor self-care, difficulty stabilising mental health 
patients, delay in discharge due to addressing social care problems or due to waiting for evaluation and 
treatment by liaison psychiatry services. The underlying reasons are likely to be multi-faceted and further 
research is required to characterise them. 
 
With the current NHS financial crisis, and the fact that £1 in every £8 ($12 or €10) spent on chronic 
conditions is related to poor mental health
47
, it is clear that curtailing mental health costs could have a large 
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impact on NHS expenditure. We have demonstrated that heart failure patients with psychiatric comorbidities 
had significantly prolonged hospital LoS by about 4 days compared to those without one, and this excess 
stay was even greater in bipolar patients who stayed in hospital for 8 days longer. Each excess inpatient day 
for heart failure patients costs £275 ($410 or €380) 
9
. Targeting this prolonged LoS could be an important 
way to reduce NHS expenditure and could be accomplished through faster diagnosis, optimization of care 
and working with community services in order to facilitate early discharge from hospital.
48
. This approach has 
previously shown to be realistic, as demonstrated by Basildon and Thurrock University Hospital. In the year 
2009/2010, the median LoS for heart failure admissions was reduced from 12 to 4 days, which released 
1,249 bed days per year and saved £312,250 ($470,000 or €440,000) 
47
. Targeting the prolonged hospital 
stay that we have demonstrated in heart failure patients with psychiatric comorbidities (namely bipolar 
disorder, dementia and depression) could therefore be an effective and realistic way of reducing NHS 
expenditure. 
 
 
Limitations 
Whilst the data encompasses a large number of patients and is therefore generalisable to the area studied 
(North West England, UK), the patient dataset is only based on one area of the UK and it is therefore not 
possible to generalise them to other areas. This is particularly important given our previously published data 
demonstrating that the prevalence of psychiatric comorbidities amongst cardiovascular patients varies 
considerably between Birmingham and Manchester 
32,33
. Furthermore, we have not studied the difference in 
severity or length of diagnosis of heart failure in those with and without psychiatric comorbidities which could 
have contributed to our positive findings. A further development to this study would be the investigation of 
the length of the diagnosis of heart failure on psychiatric diagnoses and length of hospital stay.  Lastly, we 
used LoS as a surrogate marker for the economic cost of the admission. Even though admissions generally 
cost more as the duration increases, many other factors, would contribute to the overall cost of the 
admission. Similarly, it cannot be assumed that a shorter admission will always be advantageous in terms of 
patient outcomes, and a premature discharge could lead to readmissions with longer hospital stays as well 
as poorer mortality. Patients with HF are cared for by specialist members of the multidisciplinary team, 
including HF specialist nurses and community based HF care. These services were available in the hospitals 
studied and in the community in the study locations.  However it is plausible that varying access and 
availability to these services could have had an effect on length of stay and needs to be investigated further.  
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Conclusion 
The findings of this study stress the importance of clinicians having a good awareness of mental health 
comorbidities in heart failure patients as well as a knowledge of their effective management in order to 
attempt to curtail the length of prolonged LoS. As an estimated £1 of every £8 spent by the NHS in England 
on chronic disease management is related to mental health comorbidity
47
, this will not only benefit the patient 
in terms of less time spent in hospital, but also help to reduce the huge financial burden in the healthcare 
system. Having an awareness of the susceptibility of these patients for prolonged LoS could facilitate 
proactive discharge planning for this patient group. 
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Table 1: Demographics amongst patients admitted with heart failure 
 
Total number of heart failure patients 31 760 
Mean Age±sd (years) 73.6±13.6 
n (%) Deceased 21 090 (66.4%) 
n (%) Male 15 965 (50.3%) 
Ethnicity  n (%)   
     Caucasian 27 031  (85.1%) 
     South Asian 1 326 (4.2%) 
     Afro-Carribean 455 (1.4%) 
     Oriental 73 (0.2%) 
     Mixed  45 (0.1%) 
     Other 358 (1.1%) 
     Unknown 2 472 (7.8%) 
Mean length of stay±sd (days)   11.6±20.2 
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Table 2: Length of stay in patients with heart failure and comorbid diagnoses 
Psychiatric Diagnoses 
 
Prevalence 
n (%) 
Mean LoS 
(Days) 
Mean Difference in LoS  
(95% confidence intervals) 
Physical Comorbidities 
  Type 2 Diabetes Mellitus 7021 (22.1%) 10.8 -1.1 (-1.6 - -0.5)*** 
  Hypertension 13808 (43.5%) 10.8 -1.4 (-1.9- -1.0)*** 
  Cerebrovascular Disease 2655 (8.36%) 19.9 9.0 (8.2-9.8)*** 
  Chronic Kidney Disease 4881 (15.4%) 12.8 1.5 (0.8-2.1)*** 
  Atrial Fibrillation 10992 (34.6%) 12.8 1.8 (1.3-2.3)*** 
  Anaemia 3823 (12.0%) 14.9 3.7 (3.0-4.4)*** 
Psychiatric Comorbidities 
  No psychiatric co morbidity 27757 (87.4%) 11.2 0.0 # 
  All psychiatric co morbidities  4042 (12.7%) 14.5 3.3 (2.6-3.9)*** 
  Dementia (All types) 2152 (6.78%) 15.5 4.2 (3.3-5.1)*** 
  Depression 1025 (3.23%) 14.9 3.4 (2.1-4.7)*** 
  Alcohol Abuse 581 (1.83%) 11.4 -0.2 (-1.7-1.2) 
  Anxiety Disorders 350 (1.10%) 10.3 -1.3 (-4.1-1.5) 
  Schizophrenia 179 (0.56%) 13.0 1.4 (-2.1-4.9) 
  Opioid Abuse 84 (0.26%) 15.4 3.8 (-3.4-11.0) 
  Bipolar Disorder 58 (0.18%) 20.4 8.8 (3.5-14.2)*** 
  Parasuicide 49 (0.15%) 11.1 -0.5 (-7.5-6.6) 
  Phobic Disorders 44 (0.14%) 8.1 -3.5 (-7.1- 0.0) 
  Overdose 39 (0.12%) 7.9 -3.7 (-10.4-2.9) 
Number of psychiatric comorbidities 
1 3595 (11.3%) 14.7 3.6 (2.7-4.4)*** 
2 387 (1.2%) 12.0 1.8 (-1.0-4.6) 
3 48 (0.2%) 9.9 -1.3 (-7.8-5.3) 
4 12 (0.0%) 7.1 -4.0 (-10.2-2.1) 
The absolute difference in the mean LoS in heart failure patients with the psychiatric/physical 
diagnoses are compared to all patients with heart failure who do not have each diagnosis. Difference 
in length of stay is measured in days and presented with 95% confidence intervals. A positive value 
represents a longer length of stay in the group with comorbid illness. 
 
# Patients with psychiatric/physical comorbidities were compared to those without each comorbidity 
LoS= Length of hospital stay  NOS = Not Otherwise Specified    *= p<0.05  **= p<0.01  ***= p<0.001 
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